VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 144 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,676 | -63.7% | 2,634 | -5.3% | 0.00% | – |
| Q2 2023 | $67,892 | +23.9% | 2,780 | +18.5% | 0.00% | – |
| Q1 2023 | $54,778 | -15.9% | 2,346 | -8.6% | 0.00% | – |
| Q4 2022 | $65,164 | -10.7% | 2,566 | -31.7% | 0.00% | – |
| Q3 2022 | $73,000 | +128.1% | 3,758 | +198.7% | 0.00% | – |
| Q2 2022 | $32,000 | -87.8% | 1,258 | -84.5% | 0.00% | -100.0% |
| Q1 2022 | $262,000 | -34.0% | 8,106 | -17.5% | 0.00% | 0.0% |
| Q4 2021 | $397,000 | +15.7% | 9,826 | +9.4% | 0.00% | 0.0% |
| Q3 2021 | $343,000 | +3.9% | 8,980 | +20.8% | 0.00% | 0.0% |
| Q2 2021 | $330,000 | -11.1% | 7,431 | +0.3% | 0.00% | 0.0% |
| Q1 2021 | $371,000 | -29.1% | 7,409 | -62.0% | 0.00% | 0.0% |
| Q4 2020 | $523,000 | +868.5% | 19,510 | +1160.3% | 0.00% | – |
| Q3 2020 | $54,000 | -53.8% | 1,548 | -46.1% | 0.00% | – |
| Q2 2020 | $117,000 | +21.9% | 2,870 | +2.5% | 0.00% | – |
| Q1 2020 | $96,000 | – | 2,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
| Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
| Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
| Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
| DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
| SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
| Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
| BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
| SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |